Bank of New York Mellon’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $2.76K | Hold |
|
|||||
|
2024
Q2 | $4.06K | Hold |
|
|||||
|
2024
Q1 | $6.77K | Hold |
|
|||||
|
2023
Q4 | $3.27K | Hold |
|
|||||
|
2023
Q3 | $2.4K | Hold |
|
|||||
|
2023
Q2 | $24.7K | Hold |
|
|||||
|
2023
Q1 | $39.6K | Hold |
|
|||||
|
2022
Q4 | $19.7K | Buy |
|
|||||
|
2022
Q3 | $51K | Hold |
|
|||||
|
2022
Q2 | $32K | Sell |
|
|||||
|
2022
Q1 | $41K | Hold |
|
|||||
|
2021
Q4 | $49K | Sell |
|
|||||
|
2021
Q3 | $52K | Hold |
|
|||||
|
2021
Q2 | $61K | Sell |
|
|||||
|
2021
Q1 | $339K | Sell |
|
|||||
|
2020
Q4 | $404K | Sell |
|
|||||
|
2020
Q3 | $1.53M | Buy |
|
|||||
|
2020
Q2 | $820K | Buy |
|
|||||
|
2020
Q1 | $63K | Buy |
|
|||||
|
2019
Q4 | $54K | Sell |
|
|||||
|
2019
Q3 | $56K | Hold |
|
|||||
|
2019
Q2 | $57K | Hold |
|
|||||
|
2019
Q1 | $63K | Sell |
|
|||||
|
2018
Q4 | $53K | Hold |
|
|||||
|
2018
Q3 | $57K | Sell |
|
|||||
|
2018
Q2 | $58K | Sell |
|
|||||
|
2018
Q1 | $59K | Buy |
|
|||||
|
2017
Q4 | $58K | Hold |
|
|||||
|
2017
Q3 | $61K | Hold |
|
|||||
|
2017
Q2 | $62K | Hold |
|
|||||
|
2017
Q1 | $63K | Sell |
|
|||||
|
2016
Q4 | $39K | Sell |
|
|||||
|
2016
Q3 | $38K | Sell |
|
|||||
|
2016
Q2 | $44K | Sell |
|
|||||
|
2016
Q1 | $49K | Buy |
|
|||||
|
2015
Q4 | $52K | Hold |
|
|||||
|
2015
Q3 | $42K | Hold |
|
|||||
|
2015
Q2 | $66K | Buy |
|
|||||
|
2015
Q1 | $78K | Buy |
|